Literature DB >> 32311745

Methylene Blue versus Coil-Based Computed Tomography-Guided Localization of Lung Nodules.

Ze-Dong Zhang1, Hua-Long Wang1, Xian-Yan Liu1, Feng-Fei Xia1, Yu-Fei Fu2.   

Abstract

BACKGROUND: Preoperative computed tomography (CT)-guided localization has been shown to significantly improve lung nodule video-assisted thoracoscopic surgery (VATS)-based wedge resection technical success rates. However, at present, there was insufficient research regarding the optimal approaches to localization of these nodules prior to resection. We aimed to compare the relative clinical efficacy of preoperative CT-guided methylene blue and coil-based lung nodule localization.
METHODS: In total, 91 patients with lung nodules were subjected to either CT-guided methylene blue (n = 34) or coil (n = 57) localization and VATS resection from January 2014 to December 2018. We compared baseline data, localization-associated complication rates, as well as the technical success of localization and resection between these two groups of patients.
RESULTS: In total, 42 lung nodules in 34 patients underwent methylene blue localization, with associated localization and wedge resection technical success rates of 97.6 and 97.6%, respectively. A total of 71 lung nodules in 57 patients underwent coil localization, with associated localization and wedge resection technical success rates of 94.4 and 97.2%, respectively. There were no significant differences in technical success rates of localization or wedge resection between these groups (p = 0.416 and 1.000, respectively). The coil group sustained a longer duration between localization and VATS relative to the methylene blue group (13.2 vs. 2.5 hours, p = 0.003).
CONCLUSION: Both methylene blue and coil localization can be safely and effectively implemented for conducting the diagnostic wedge resection of lung nodules. The coil-based approach is compatible with a longer period of time between localization and VATS procedures. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32311745     DOI: 10.1055/s-0040-1708836

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  7 in total

1.  Handheld PET Probe for Pediatric Cancer Surgery.

Authors:  Hannah N Rinehardt; Sadie Longo; Ryan Gilbert; Jennifer N Shoaf; Wilson B Edwards; Gary Kohanbash; Marcus M Malek
Journal:  Cancers (Basel)       Date:  2022-04-29       Impact factor: 6.575

2.  Computed tomography-guided trans-pulmonary-hepatic approach coil localization for pulmonary nodules near the right lung base.

Authors:  Ya-Ge Zheng; Tao Wang; Pan-Hao Rong; Yu-Fei Fu
Journal:  Kardiochir Torakochirurgia Pol       Date:  2021-10-05

3.  Clinical-radiological predictive model in differential diagnosis of small (≤ 20 mm) solitary pulmonary nodules.

Authors:  Hai-Cheng Zhao; Qing-Song Xu; Yi-Bing Shi; Xi-Juan Ma
Journal:  BMC Pulm Med       Date:  2021-09-05       Impact factor: 3.317

4.  Coil localization assisted wedge resection for pulmonary nodules in patients with malignant history.

Authors:  Qing-Song Xu; Tao Wang; Wei Cao; Pan-Hao Rong
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

Review 5.  Fluorescence-guided lung nodule identification during minimally invasive lung resections.

Authors:  Riccardo Tajè; Filippo Tommaso Gallina; Daniele Forcella; Giulio Eugenio Vallati; Federico Cappelli; Federico Pierconti; Paolo Visca; Enrico Melis; Francesco Facciolo
Journal:  Front Surg       Date:  2022-07-18

6.  Computed tomography-guided core needle biopsy for lung nodules: low-dose versus standard-dose protocols.

Authors:  Yi-Yang Huang; Hong Cheng; Guang-Chao Li
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-02-03       Impact factor: 1.195

7.  Computed tomography-guided localization for multiple pulmonary nodules: a meta-analysis.

Authors:  Xia Tang; Hong-Mei Jian; Yi Guan; Jie Miao; Xin Liang
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-03-08       Impact factor: 1.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.